Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT03066089
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 104 participants
- Sponsor
- Chemical Resources
- Registry
-
NCT03066089
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT03066089. Non-randomized; no masking; primary purpose supportive care. Start 2015-12-14 (actual); primary completion 2017-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Fenfuro
- Lead sponsor
- Chemical Resources
Record details
- Record id
cardio:ct-nct03066089- Content hash
de03c7d34dbff1ccf9c22643f8f0f38e0c69d0003095ded4382c9f095470546d